Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Gilat Satellite Networks Ltd. announced a $28 million contract awarded to its Peruvian subsidiary to enhance broadband connectivity in the Ica region of Peru. The project includes network upgrades that will deliver internet speeds 20 times faster to public institutions and expand free Wi-Fi access to public squares, with construction to be complete…
Alterity Therapeutics presented additional analyses from its Phase 2 trial of ATH434 in Multiple System Atrophy (MSA), demonstrating that the 50 mg dose significantly slowed functional decline by approximately 52% compared to placebo at 52 weeks when adjusted for baseline disease severity using CSF neurofilament light chain (NfL). The findings supp…
PALAF trades at $6.53 with technicals weak but short interest at multi-month highs (17.1M on 09/15/2026). If uranium spot climbs into the $70–$96 per pound band, Paladin’s leverage to the commodity and the crowded short book create an asymmetric risk/reward. This is a high-risk swing trade: entry $6.50, stop $4.50, target $12.00 over ~45 trading da…
DoubleVerify (DV) announced the launch of attribution measurement for ChatGPT advertising, enabling advertisers to assess the impact of ChatGPT Ads within the broader customer journey and improve return on ad spend. Additionally, DV and OpenAI are collaborating on a brand suitability evaluation pilot to ensure ad placements align with brand safety …
VisionWave Holdings, Inc. outlines the development of its integrated autonomous defense ecosystem, featuring a range of tactical UAVs for ISR, logistics, strike, and counter-UAS applications. None of the platforms are currently in production or have customer orders. The company is actively pursuing U.S. and international counter-UAS contracts but h…
BioCryst Pharmaceuticals has established a Scientific Advisory Board composed of experts in rare disease research and drug development to guide its R&D strategy and pipeline growth. This move supports the company's transition to an innovation-driven R&D model focusing on external partnerships and advancing therapies for rare diseases, including her…
Alector has entered an exclusive licensing agreement with Genentech, granting worldwide rights to develop and commercialize its AL050 brain-penetrant GCase enzyme replacement therapy targeting Parkinson's disease and other neurodegenerative conditions. The deal includes a $100 million upfront payment, potential milestones totaling $1.17 billion, an…
Psyence Biomedical Ltd., via its Texas subsidiary Texas Ibogaine Research Corporation (TIRC), has partnered with Benuvia Operations, a DEA-registered controlled substance manufacturer in Texas, to establish U.S. manufacturing of pharmaceutical-grade ibogaine active pharmaceutical ingredient (API). This partnership aims to integrate Psyence BioMed’s…
Harrow, Inc. announced the closing of its acquisition of TYRVAYA (varenicline solution) nasal spray from Viatris, securing global rights except for Japan. TYRVAYA is the first FDA-approved nasal spray for dry eye disease (DED) and complements Harrow's existing DED therapy, VEVYE. The acquisition expands Harrow's commercial footprint in the growing …
Iridex Corporation has completed the relocation of its manufacturing facility from Mountain View to San Jose, California. This move is aimed at reducing expenses and enhancing operational efficiency, with expected annualized cost savings of approximately $0.6 million. The relocation supports the company's future growth plans and profitability impro…
TurboGen Ltd. announces a multi-year agreement with a top-tier European engineering and manufacturing company to transition from prototype to serial production of its 20kW combined heat and power microturbine systems, targeting both defense and civilian markets. This partnership aims to facilitate commercialization, enhance revenue streams, and exp…
Baker Hughes announced two strategic agreements with PDVSA, Lindsayca, Fulcrum LNG, and New Stratus Energy aimed at revitalizing Venezuela's natural gas infrastructure and expanding oil and gas production. These partnerships seek to develop an integrated gas value chain for domestic supply, LNG export potential, and supporting Venezuela's role in t…
Rezolute, Inc. announced that the FDA has recommended a pre-BLA meeting following review of Phase 3 sunRIZE study data for ersodetug, a treatment candidate for congenital hyperinsulinism. Although sunRIZE did not meet its primary endpoint, consistent clinical improvements were observed, prompting the agency to encourage further evaluation through a…
Satellos Bioscience Inc., a clinical-stage drug developer focused on degenerative muscle diseases, has been granted a U.S. composition of matter patent for forazapadin, its lead clinical-stage drug candidate targeting AAK1 inhibition to promote muscle regeneration. The patent offers protection through September 2044 with potential extension after F…
Americold Realty Trust, a leader in temperature-controlled logistics and real estate, announced it will release its third quarter 2026 financial results before market open on November 5, 2026, followed by a conference call. The company operates over 220 facilities globally, providing critical services in the refrigerated supply chain.
Nurix Therapeutics and Gilead Sciences have agreed to a second two-year extension of their research collaboration on an undisclosed oncology program, underscoring the productive partnership initiated in 2019. Nurix retains co-development and profit-sharing options for up to two programs in the U.S., and will receive a $10 million extension fee. The…
Electra Battery Materials Corporation appoints Garzon Duenas as General Manager to lead commissioning and operations of its Ontario cobalt sulfate refinery. Construction is on budget with commissioning expected to start in Q4 2026 and commercial production targeted for Q4 2027. The refinery aims to be North America's first battery-grade cobalt sulf…
Wabash National Corporation (NYSE: WNC) has scheduled its third quarter 2026 earnings conference call for October 29, 2026, at 12:00 p.m. ET. The call will be webcast and accompanied by a slide presentation accessible in the investors section of the company's website. Financial results, along with presentation materials, will be posted prior to the…
Pharvaris released results from a multinational real-world analysis of hereditary angioedema (HAE) management, revealing significant gaps between guideline-recommended care and actual patient experiences. The study highlights treatment adherence challenges, patient preferences favoring oral therapies, and ongoing unmet needs despite advances in HAE…
Hilton Grand Vacations ($HGV) has been punished on macro headlines despite healthy fundamentals: free cash flow of $374M, a market cap near $2.7B, and multiple valuation cushions versus longer-term targets. With RSI at 26 and growing short interest, the risk/reward favors a tactical long over the next 45 trading days.
SFL Corporation Ltd. has ordered two advanced 93,000 cbm Very Large Ammonia Carriers with delivery set for 2028 at a cost of approximately $216 million. These vessels will carry various petrochemical gases, feature dual-fuel propulsion, and use cutting-edge technology for efficiency. Concurrently, SFL secured long-term time charters from a European…
LyondellBasell (NYSE: LYB), a leading global chemical company, will release its third-quarter 2026 financial results before the U.S. market opens on Friday, October 30, 2026. The company will hold a webcast and teleconference the same day at 11 a.m. EDT to discuss the results. The announcement includes details on accessing the webcast, teleconferen…
Fortrea, a Nasdaq-listed global contract research organization, announced it will release its third quarter 2026 financial results on October 29, 2026, before market open, followed by a conference call at 8:00 a.m. ET to discuss results. The company provides clinical development solutions for biopharmaceutical and medical device sectors worldwide.
Gold.com (GOLD) is trading near $42 with free cash flow roughly equal to the company's market cap and a near-2% yield. Technicals show short-term weakness but fundamentals imply an asymmetric risk/reward for a mid-term long. This trade idea lays out an entry, stop, targets and the catalysts and risks investors should track.
HSBC said in a note released Monday that its machine learning models signal a risk-on environment for equities following a volatile stretch in markets. The bank's cycle indicator, ECCLES, classifies the current regime as Late Cycle and views that setting as constructive for US and growth equities. Complementary models point to a low chance of near-…
